Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 18/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 17/20 | 0.59 |
| ▸ | DRD2 | P14416 | 14/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5101657 | 0.92 | DRD3 (0.62) | DRD3KCNH2DRD2HRH1 | |
| SCHEMBL4765674 | 0.89 | DRD3 (0.73) | DRD3KCNH2DRD2 | |
| SCHEMBL5111233 | 0.80 | DRD3 (0.77) | DRD3KCNH2DRD2HRH1 | |
| SCHEMBL4770243 | 0.76 | DRD3 (0.80) | DRD3KCNH2DRD2 | |
| SCHEMBL4769737 | 0.75 | DRD3 (0.61) | DRD3KCNH2DRD2HRH1 | |
| SCHEMBL5098678 | 0.75 | DRD3 (0.65) | DRD3KCNH2DRD2 | |
| SCHEMBL4773242 | 0.74 | DRD3 (0.75) | DRD3KCNH2DRD2 | |
| SCHEMBL5104734 | 0.74 | DRD3 (0.77) | DRD3KCNH2DRD2 | |
| SCHEMBL5105134 | 0.73 | DRD3 (1.00) | DRD3KCNH2DRD2HRH1 | |
| SCHEMBL5102569 | 0.73 | DRD3 (0.62) | DRD3KCNH2DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7429579-B2 | Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) | SMITHKLINE BEECHAM, PLC (GB) | 2008-09-30 | — | — | US | claimed |
| US-7429579-B2 | Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) | SMITHKLINE BEECHAM, PLC (GB) | 2008-09-30 | — | — | US | disclosed |